Intuitive Surgical, Inc. $ISRG Shares Sold by William Blair Investment Management LLC

William Blair Investment Management LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 38.3% in the 3rd quarter, Holdings Channel reports. The fund owned 22,072 shares of the medical equipment provider’s stock after selling 13,703 shares during the period. William Blair Investment Management LLC’s holdings in Intuitive Surgical were worth $9,871,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Tobam boosted its holdings in Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at about $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $27,000. Caitlin John LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $30,000. Finally, Guerra Advisors Inc acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $37,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $208,378.16. Following the transaction, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. This trade represents a 50.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president owned 660 shares of the company’s stock, valued at approximately $326,673.60. This represents a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 33,603 shares of company stock valued at $17,875,660 over the last three months. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Evercore lowered their target price on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a report on Friday, January 23rd. Barclays set a $712.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. UBS Group set a $570.00 target price on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Tuesday, February 24th. Truist Financial raised their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Finally, Sanford C. Bernstein boosted their price objective on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $615.86.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $497.42 on Wednesday. The firm’s 50-day simple moving average is $526.56 and its 200-day simple moving average is $512.18. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88. The firm has a market cap of $176.65 billion, a P/E ratio of 63.04, a PEG ratio of 3.83 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the prior year, the business posted $2.21 earnings per share. Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. Analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.